Navigation Links
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
Date:3/4/2013

r/>3.3.7 Market Drivers 34
3.3.8 Market Restraints 34
3.4 Idiopathic Thrombocytopenic Purpura: Research and Development Pipeline 35
3.4.1 Overview 35
3.4.2 Pipeline by Clinical Phase of Development 36
3.4.3 Trends in Idiopathic Thrombocytopenic Purpura Pipeline 40
3.4.4 Promising Pipeline Molecules 41
3.4.5 Key Takeaway 43
3.5 Myelodysplastic Syndrome 44
3.5.1 Disease Overview 44
3.5.2 Revenues 45
3.5.3 Revenue Analysis by Country 46
3.5.4 Annual Cost of Therapy 50
3.5.5 Treatment Usage Patterns 51
3.5.6 Marketed Products 52
3.5.7 Market Drivers 53
3.5.8 Market Restraints 53
3.6 Myelodysplastic Syndrome: Research and Development Pipeline 54
3.6.1 Overview 54
3.6.2 Pipeline by Clinical Phase of Development 55
3.6.3 Trends in Myelodysplastic Syndrome Pipeline 80
3.6.4 Promising Pipeline Molecules 83
3.6.5 Key Takeaway 83
3.7 Myelofibrosis 84
3.7.1 Disease Overview 84
3.7.2 Revenues 85
3.7.3 Revenue Analysis by Country 86
3.7.4 Annual Cost of Therapy 90
3.7.5 Treatment Usage Patterns 91
3.7.6 Marketed Products 92
3.7.7 Market Drivers 92
3.7.8 Market Restraints 92
3.8 Myelofibrosis: Research and Development Pipeline 93
3.8.1 Overview 93
3.8.2 Pipeline by Clinical Phase of Development 94
3.8.3 Trends in Myelofibrosis Pipeline 99
3.8.4 Promising Pipeline Molecules 101
3.8.5 Key Takeaway 101
3.9 Polycythemia Vera 102
3.9.1 Disease Overview 102
3.9.2 Revenues 103
3.9.3 Revenue Analysis by Country 104
3.9.4 Annual Cost of Therapy 108
3.9.5 Treatment Usage Patterns 109
3.9.6 Marketed Products 110
3.9.7 Market Drivers 111
3.9.8 Market Restraints 111
3.10 Polycythemia Vera: Research and Development Pipeline 112
3.10.1 Overview 112
3.10.2 Pipeline by Clinical Phase of Development 113
3.10.3 Trends in Polycythemia Vera Pipeline 116
3.10.4 Promising Pipeline Molecules 118
3.10
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
2. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
3. Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC
4. Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections
5. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
8. FDA Grants Orphan Drug Status To Eisais Lenvatinib
9. Lentigen Receives U.S. Orphan Drug Designation for Novel Gene Therapy for glioblastoma multiforme
10. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
11. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
(Date:7/31/2015)... 2015  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... Hata to its board of directors. ... development is a tremendous asset to our board," said ... officer of Xencor. "Xencor faces a range of opportunities ...
(Date:7/30/2015)... , July 30, 2015  ResMed (NYSE: ... signed a definitive agreement to acquire Curative ... ventilation and sleep-disordered breathing medical devices and ... market reputation in China, combined with ResMed,s global leadership in sleep and ... China suffering from ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... Calif., Oct. 27 ... beamforming technology, analog-front-end semiconductors and solutions for the ... Ultrasound Beamforming Development Kit.  Based on Samplify,s AutoFocus™ ... solution for the ultrasound front end, from probe ...
... Oct. 27 Solos Endoscopy, Inc. (Pink Sheets: ... revenues during the three months ended September 30, 2010 in ... ended September 30, 2009.  This was an increase of 34.8% for ... Despite a down global economy, Solos has been able ...
Cached Medicine Technology:Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 3Solos Endoscopy, Inc. Revenue Grows 34.8% for Third Quarter 2010 2
(Date:7/31/2015)... ... ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based in Seattle, ... it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use a promising ... will grant 100% of the money raised to BioViva to help bring pioneering gene ...
(Date:7/31/2015)... Church, VA (PRWEB) , ... July 31, 2015 ... ... Way, Oct. 20-21, 2015 – Washington, DC, http://www.fdanews.com/importexportprogram , Having FDA-regulated ... it doesn’t have to. , Instead of risking containment — or even destruction ...
(Date:7/31/2015)... Tampa, FL (PRWEB) , ... July 31, 2015 ... ... cancer patients using the RenovoCath,™ a novel catheter that was developed for targeted ... locally-advanced pancreatic cancer are now being treated at Florida Hospital Tampa with the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... Birmingham. The U.S. Women's National Soccer Team will face the Australia Women's National Team ... September 17th at Ford Field in Detroit and the second match will occur in ...
(Date:7/31/2015)... ... ... Indosoft, Inc., is pleased to announce a major update to its agent interface ... ACD system for Asterisk-based call centers . The new features make it easier ... agent only when wanted, and allows for validation of data as the agent enters ...
Breaking Medicine News(10 mins):Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2
... Accepts as Complete DNV,s ... Hospital Deeming Authority, HOUSTON, March 24 The U.S. ... that its application to,deem hospitals in compliance with the Medicare ... formal review., If approved, DNV stands to become the ...
... Control of all Sites from a Single ... ... Dayton,Ohio has chosen multiple products from Sage Software - including the,Intergy by ... and improve the,patient experience. Previously, Digestive Specialists used The Medical,Manager by Sage., ...
... March 24 MedCath Corporation,(MedCath) (Nasdaq: MDTH ... Ohio) jointly announced today that the parties have,entered ... Samaritan,Hospital will acquire substantially all of Dayton Heart ... $55.0 million, a portion of,which is allocated to ...
... they,re not getting needed screenings for breast and cervical tumors ... of 32 studies suggests that obese women -- particularly white ... for breast and cervical cancer. , No one knows ... mammograms or Pap smears. And it,s not known why obesity ...
... BOSTON, March 24 "Going head-to-head with your child,can be ... ask,for some extra reading at bedtime and, before you know ... that you can,t refuse.,Well, if I can,t stay up late ... I guess you owe me a back rub and two ...
... Joint ST/Veredus lab set up in Singapore to develop future lab-on-chip ... ... SINGAPORE, March 24 Following the,success of the evaluation trials conducted ... STM ) today announced the commercial availability,of VereFlu(TM), a portable ...
Cached Medicine News:Health News:DNV Healthcare Advances in Bid to Accredit Hospitals 2Health News:Multi-site Gastro Practice Chooses Intergy by Sage Practice Management System 2Health News:MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton 2Health News:MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton 3Health News:Obese Women Less Likely to Be Tested for Some Cancers 2Health News:HOW TO UNSPOIL YOUR CHILD FAST: Harvard Medical School Psychologist Writes Book to Guide and Motivate Parents and Support the Children's Defense Fund 2Health News:STMicroelectronics and Veredus Laboratories Launch Market's First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need 2Health News:STMicroelectronics and Veredus Laboratories Launch Market's First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need 3
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Red Lens Maddox...
The Snellen chart is the default optotype with the standard order of letters (T Z V E C L) as default. When the Refresh 'R' button is pressed, the letters ( or pictures ) are replaced with a random s...
Snellen 20' Eye Test Chart....
Medicine Products: